Select Publications
Journal articles
2016, 'Percutaneous Coronary Intervention in the Very Elderly Patients (>0): Comparison of Efficacy and Safety Outcomes with the Younger Cohort', Heart, Lung and Circulation, 25, pp. S187 - S187, http://dx.doi.org/10.1016/j.hlc.2016.06.438
,2015, 'Optimal duration of dual antiplatelet therapy following drug-eluting stents implantation: A meta-analysis of 7 randomised controlled trials', International Journal of Cardiology, 201, pp. 578 - 580, http://dx.doi.org/10.1016/j.ijcard.2015.03.073
,2015, 'Peri-procedural myocardial infarction following percutaneous coronary intervention as defined by the Universal Definition predicts increased mortality at 2 years', International Journal of Cardiology, 199, pp. 96 - 98, http://dx.doi.org/10.1016/j.ijcard.2015.07.023
,2015, 'Everolimus-eluting Bioresorbable Vascular Scaffold Implantation in Real World and Complex Coronary Disease: Procedural and 30-day Outcomes at Two Australian Centres', Heart Lung and Circulation, 24, pp. 854 - 859, http://dx.doi.org/10.1016/j.hlc.2015.02.011
,2015, 'Prognostic significance of peri-procedural myocardial infarction in the era of high sensitivity Troponin: A validation of the joint ACCF/AHA/ESC/WHF Universal definition of type 4a myocardial infarction with high sensitivity Troponin T', Heart Lung and Circulation, 24, pp. 673 - 681, http://dx.doi.org/10.1016/j.hlc.2015.01.007
,2015, 'Heart-type fatty acid binding protein in early diagnosis of myocardial infarction in the era of high-sensitivity troponin: a systematic review and meta-analysis', Annals of Clinical Biochemistry, 52, pp. 370 - 381, http://dx.doi.org/10.1177/0004563214553277
,2015, 'Ankyrin-B Syndrome: A Case of Sinus Node Dysfunction, Atrial Fibrillation and Prolonged QT in a Young Adult', Heart Lung and Circulation, 24, pp. e31 - e34, http://dx.doi.org/10.1016/j.hlc.2014.09.013
,2015, 'Australian multi-centre experience with bioresorbable vascular scaffolds in “real-world” coronary disease - twelve-month outcomes', Heart, Lung and Circulation, 24, pp. S263 - S263, http://dx.doi.org/10.1016/j.hlc.2015.06.358
,2015, 'Comparison of aerobic interval training and moderate continuous training in patients with coronary artery disease', Heart, Lung and Circulation, 24, pp. S453 - S453, http://dx.doi.org/10.1016/j.hlc.2015.06.789
,2015, 'Drug-eluting balloon versus second generation drug eluting stents in the treatment of in-stent restenosis: a systematic review and meta-analysis', Heart, Lung and Circulation, 24, pp. S273 - S273, http://dx.doi.org/10.1016/j.hlc.2015.06.381
,2015, 'Long-term safety of an Everolimus-eluting bioresorbable scaffold: two year clinical outcomes in a wide spectrum of coronary lesions', Heart, Lung and Circulation, 24, pp. S281 - S281, http://dx.doi.org/10.1016/j.hlc.2015.06.398
,2015, 'Prolonged infusion of bivalirudin improves outcomes in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomised trials', Heart, Lung and Circulation, 24, pp. S295 - S295, http://dx.doi.org/10.1016/j.hlc.2015.06.430
,2015, 'Routine debulking rotational atherectomy preparation before drug eluting balloons for the management of in-stent restenosis', Heart, Lung and Circulation, 24, pp. S300 - S300, http://dx.doi.org/10.1016/j.hlc.2015.06.441
,2014, 'PM193 Defining peri-procedural myocardial injury following percutaneous coronary intervention using high-sensitive troponin T assay', Global Heart, 9, pp. e102 - e102, http://dx.doi.org/10.1016/j.gheart.2014.03.1580
,2014, 'PM200 Australian Experience with AbsorbTM Bioresorbable Scaffold Technology in "Real-World" Coronary Disease', Global Heart, 9, pp. e104 - e104, http://dx.doi.org/10.1016/j.gheart.2014.03.1587
,2014, 'PT187 Bioresorbable scaffolds in the treatment of chronic total occlusions (CTO)', Global Heart, 9, pp. e204 - e204, http://dx.doi.org/10.1016/j.gheart.2014.03.1957
,2013, 'Early Australian Experience With AbsorbTM Bioresorbable Scaffold Technology in “Real-World” Coronary Disease', Heart, Lung and Circulation, 22, pp. S38 - S38, http://dx.doi.org/10.1016/j.hlc.2013.05.090
,2013, 'TCT-425 Real-World Experience with Absorb(tm) Bioresorbable Scaffold Technology - Early Australian Registry Results', Journal of the American College of Cardiology, 62, pp. B131 - B132, http://dx.doi.org/10.1016/j.jacc.2013.08.1166
,2012, '30 Day and Twelve Month Outcome Data from Two Combined Public/private Catheter Labs', Heart, Lung and Circulation, 21, pp. S143 - S143, http://dx.doi.org/10.1016/j.hlc.2012.05.361
,2009, 'ACE inhibitors: their propertiesand current role in hypertension', Prescriber, 20, pp. 15 - 28, http://dx.doi.org/10.1002/psb.538
,2009, 'Scedosporium apiospermum pacemaker endocarditis', International Journal of Cardiology, 131, http://dx.doi.org/10.1016/j.ijcard.2007.07.056
,2009, 'Percutaneous closure of patent foramen ovale: A single centre experience', Heart, Lung and Circulation, 18, pp. S222 - S223, http://dx.doi.org/10.1016/j.hlc.2009.05.550
,2008, 'A 2×2 Factorial Design Randomised Control Trial Assessing the Efficacy of High Pressure Coronary Stent Deployment and Post-dilation to Achieve Relative Oversize Compared to Nominal Stent Deployment and Sizing in Patients at High Risk for Re-stenosis Using the Endeavor Drug-eluting Stent Versus Bare Metal Stents: The HEADROOM trial—Report of the First 100 Patients', Heart, Lung and Circulation, 17, pp. S173 - S173, http://dx.doi.org/10.1016/j.hlc.2008.05.411
,2008, 'Feasibility and Safety of Erythropoietin (EPO) Administration in Patients with Acute Myocardial Infarction to Improve Cardiac Function and Remodelling: Pilot Study', Heart, Lung and Circulation, 17, pp. S173 - S173, http://dx.doi.org/10.1016/j.hlc.2008.05.412
,2008, 'Percutaneous Revascularisation for Unprotected Left Main Disease in High-Risk Patients: A Single Centre Experience', Heart, Lung and Circulation, 17, pp. S181 - S181, http://dx.doi.org/10.1016/j.hlc.2008.05.430
,2007, 'ACE inhibitors: their properties and current role in hypertension', Prescriber
,2004, 'Statins and rheumatoid arthritis [3] (multiple letters)', Lancet, 364, pp. 1853 - 1855, http://dx.doi.org/10.1016/S0140-6736(04)17432-1
,2000, 'Renal impairment in deoxycorticosterone acetate-salt hypertensive rats', Nephrology, 5, pp. 277 - 284, http://dx.doi.org/10.1046/j.1440-1797.2000.00013.x
,2000, 'Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats', Clinical and Experimental Pharmacology and Physiology, 27, pp. 263 - 269, http://dx.doi.org/10.1046/j.1440-1681.2000.03234.x
,